Parkinson's & Movement disorders

Blocking LRRK2 activity is not a simple answer to Parkinson's disease

Mutations in the LRRK2 gene are the most common cause of genetic Parkinson's disease (PD). New research published in BioMed Central's open access journal Molecular Neurodegeneration demonstrates that loss of function of LRRK2 ...

Cardiology

21st century bloodletting reduces cardiovascular risk

It seems that while the practice of bloodletting throughout history had little or no effect on most diseases, and the practice was abandoned in the 19th century, new research published in BioMed Central's open access journal ...

Diseases, Conditions, Syndromes

Stabilizing Fanconi anemia with antioxidants

Fanconi anemia (FA) is a rare genetic disorder which affects one person in 350,000. People affected by this disease have defects in DNA repair, and are hypersensitive to oxidative damage, resulting in bone marrow failure ...

Psychology & Psychiatry

Reducing post-traumatic stress after intensive care unit

Women are more likely to suffer post-traumatic stress than men after leaving an intensive care unit (ICU), finds a new study published in BioMed Central's open access journal Critical Care. However, psychological and physical ...

Genetics

Genetic predictor of breast cancer response to chemotherapy

Chemotherapy is a major first line defense against breast cancer. However a patient's response is often variable and unpredictable. A study published in BioMed Central's open access journal BMC Medical Genomics shows that ...

Medical research

Breastfeeding is associated with a healthy infant gut

Early colonization of the gut by microbes in infants is critical for development of their intestinal tract and in immune development. A new study, published in BioMed Central's open access journal Genome Biology, shows that ...

Diseases, Conditions, Syndromes

Study finds early signs of malaria drug resistance in Africa

Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

page 11 from 18